Category Archives: Biochemistry

ACS announces 2022 awards – ASBMB Today

In late March, the American Chemical Society announced its awards for 2022. Among the honorees were American Society for Biochemistry and Molecular Biology members Karen Allen, Benjamin Cravatt, Kimberly Jackson and Carlito Lebrilla.

Karen Allen

Karen Allen, a professor and chair of the chemistry department at Boston University, won the 2022 Abeles and Jencks Award for the Chemistry of Biological Processes. Allen's lab studies the structure, function and mechanisms of phosphatases, phosphoglycosyltransferases and decarboxylases, working to understand both reaction mechanisms and enzyme evolution. Allen is a co-organizer of the 2023 ASBMB Annual Meeting. She is the inaugural recipient of this award, which was named for the late enzymologists William Jencks and Robert Abeles, who taught and studied mechanistic enzymology at Brandeis University. Given by the ACS division of biological chemistry, the award celebrates "outstanding contributions to the understanding of the chemistry of biological processes."

Benjamin Cravatt

Benjamin Cravatt, a professor of chemistry and chair of chemical biology at Scripps Research, received the Alfred Bader Award for outstanding contributions in bioinorganic or bioorganic chemistry. Cravatt's lab developed a technique to use chemical probes that bind to and tag enzymes active sites, enabling researchers to read out enzyme activity at proteome scale. They have used the technique to study endocannabinoid signaling, cancer and neurological disorders. Researchers in the lab have also extended their methods to globally map small moleculeprotein interactions and discover chemical probes for historically undruggable proteins. Cravatt was also one of three recipients of the 2022 Wolf Prize in Chemistry, and he won the ASBMBMerck Award in 2014. The late Alfred Bader, a Canadian chemist, businessman and philanthropist, and his family established this award in 1986.

Kimberly Jackson

Kimberly Jackson, a professor and chair of the department of chemistry and biochemistry at Spelman College, received the ACS award for Encouraging Disadvantaged Students into Careers in the Chemical Sciences. Jackson is director of the food studies program at Spelman, a historically black college. Her lab studies potential therapeutic molecules for advanced prostate cancer, and many of the undergraduates who have trained with her later earned Ph.D.s or medical degrees. The award includes a prize of $10,000, which Jackson directed to an Atlanta-based nonprofit called PinkSTEM that aims to empower girls to succeed in science, technology, engineering and mathematics.

Carlito Lebrilla

Carlito Lebrilla, a distinguished professor and former chair of the chemistry department at the University of California, Davis, received the Frank H. Field and Joe L. Franklin Award for Outstanding Achievement in Mass Spectrometry. Known for his glycoproteomics work, Lebrilla studies disease biomarkers in cancer and Alzheimers disease, along with bioactive compounds breast milk and how milk glycoproteins affect infant microbiomes. Lebrilla is a member of the editorial advisory board of Molecular & Cellular Proteomics. This ACS award, sponsored by the Waters Corporation, is named for two noted mass spectrometrists; Field worked in developing chemical ionization, and Franklin studied the chemistry of ion molecules.

Go here to read the rest:
ACS announces 2022 awards - ASBMB Today

Masters in Biochemistry and Molecular Biology | Georgetown University

The Master of Science in Biochemistry & Molecular Biology at Georgetown University is a basic science program that infuses core concepts of biochemistry and molecular biology as applied to biomedical sciences and biotechnology, providing students with a rigorous and challenging curriculum. Graduates from the program excel in various career paths with government agencies, academic institutions, research laboratories, and biotechnology companies. Alumni have also continued their education by pursuing doctoral, medical, and law degrees, using the skills and training at Georgetown University to propel their future academic and research careers.

Core concepts and skills are taught through required core courses, advanced electives, special topics courses, and a 4 credit internship. At least 30 graduate credits with a cumulative GPA of 3.0 or greater are required for the M.S. degree. Our courses expose students to advanced methods in biochemistry, molecular biology, and cell biology, laboratory research, and literature-based research and include a significant number of hands-on lab-based courses that develop research expertise.

Our program offers a well-organized, intensive capstone internship program that culminates in students presenting their research at tri-annual poster presentation sessions. The internships are done with research mentors in various GUMC laboratories on-campus, or off-campus in government agencies such as NIH and FDA or biotechnology companies.

Read more:
Masters in Biochemistry and Molecular Biology | Georgetown University

‘Molecular LEGO’ Study Analyzes Building Blocks of Partially Disordered Protein | Newsroom – University of California, Merced

Bioengineering Professor Victor Muoz and his lab have created a new way to solve some of the mysteries among an increasingly important class of proteins that dont appear to have any specific structures but serve very important functions, including the complex genetic processes that separate high-order organisms from single-cell bacteria.

They call it molecular LEGO, pulling the proteins apart and rebuilding them, segment by segment.

This new method could dramatically affect a relatively young and exploding field within biochemistry and biomolecular sciences for researchers worldwide.

Molecular LEGO is detailed in a new paper entitled A Modular Approach to Map Out the Conformational Landscapes of Unbound Intrinsically Disordered Proteins in the Proceedings of the National Academies of Science, out now.

For the past four decades, biochemists and biomolecular engineers have used techniques such as X-ray crystallography, NMR and cryo-electron microscopy to study proteins that fold into defined structures that dictate how they work like the tiny machines they are.

Scientists have also traditionally used a method to help understand what makes these proteins behave as they do. They create mutations in the protein, changing single amino acids, and studying how much that change affects the proteins structure, stability, and the rates of folding and unfolding.

Its the only experimental technique we have for studying what makes a particular amino acid sequence special to fold into one particular structure and serve one particular function, Muoz said.

Intrinsically disordered proteins (IDPs), discovered in the past 20 years, dont have apparent structures at least none that current techniques can discern. They change shapes based on their environments and conditions and tend to fold into structures when they bind specific partner molecules. They have the unique ability to morph in response to multiple partners and can process sophisticated inputs and outputs.

But its a mystery whether their response is passive entirely determined by the partner or controlled via an internal folding mechanism that has yet to be revealed.

That is the question Muoz and his group are trying to answer as they experiment with and model a partially disordered protein called NCBD to uncover clues as to how it performs its sophisticated biological function. They take this disordered protein and make it even more disordered by breaking NCBD into pieces and studying each one separately.

Thats the most disordered thing you can have because youve removed all the connections, Muoz said. But those are the LEGO building blocks. They give us a reference point.

Then the researchers recombine the segments in order, one at a time, to see how each restored, larger segment behaves.

Is it just the sum of its parts or some cooperation between the connected parts? he said.

Ordered proteins behave as if they have on and off switches, while IDPs seem to work more like rheostats, changing gradually.

It could turn out that IDPs only appear disordered because scientists are looking at them using techniques that dont give them the whole picture. The IDPs must have some structure because they are able to select specific partners, change shape when bound to those partners and complete complicated actions in very specific ways, Muoz explained.

Muoz wrote the paper with graduate students Thinh D.N. Luong, in the Chemistry and Chemical Biology program and Suhani Nagpal, in the Bioengineering program, as well as Mourad Sadqi, a project scientist with the NSF-CREST Center for Cellular and Biomolecular Machines (CCBM), for which Muoz serves as director.

More IDPs are being discovered and are quickly becoming a very important class of proteins. They are more commonly found in high-order organisms, such as humans.

It seems like the paradigm that is emerging is that all these proteins are key in regulation and responsible for all the complexity that is emerging in high-order organisms without having to vastly increase the number of genes, Muoz said.

For example, an E. coli bacterium has about 5,000 genes, while a human has about 30,000.

So, you can see that we definitely have to do something special with those 30,000 genes to make us, compared with a bacterium, a very simple thing, Muoz said. The thought is that this is achieved by sophisticated regulation, networks and other complicated processes, and it seems like the key players in all this are these IDPs. They are often found at the hubs in these networks.

The next steps for this work will be to apply the new technique to other proteins and to recombine the proteins outside the segment order defined by the gene sequence to see how that affects the segments and function.

This connects with a lot of our engineering work in which were trying to build biosensors and new methods for diagnostics, Muoz said. We can use these proteins as the scaffolds to make responsive systems on the molecular level.

Read the rest here:
'Molecular LEGO' Study Analyzes Building Blocks of Partially Disordered Protein | Newsroom - University of California, Merced

Senior Lecturer or Associate Professor in Biochemistry and Pharmacology job with UNIVERSITY OF MELBOURNE | 295930 – Times Higher Education

Location: ParkvilleRole type: Full time /ContinuingFaculty: Faculty of Medicine, Dentistry and Health SciencesDepartment/School:Department of Biochemistry and PharmacologySalary: Level C ($135, 032 - $155,698) OR Level D ($162,590 - $179,123) p.a. plus 17% super

Founded in 1853, the University of Melbourne is Australias #1 university and is consistently ranked amongst the leading universities in the world. We are proud of our people, our commitment to research and teaching excellence, and our global engagement.

About theDepartment of Biochemistry and Pharmacology

The Department of Biochemistry and Pharmacology is committed to developing the careers and wellbeing of our students and staff, fostering a culture that supports us all to do our best work. We are guided by our values in our pursuit of excellence.The Department of Biochemistry and Pharmacology has critical mass, interdisciplinary teaching and a remarkable breadth and depth in research expertise that underpin our key themes of molecular understanding of biology and disease, translational research, drug discovery and development. Our researchers are strongly committed to high-impact discovery research and in translating breakthroughs to societal outcomes when the opportunity arises.

The Department of Biochemistry and Pharmacology is strongly committed to supporting diversity and the representation of women. In line with the special measure H103/2014 provided for under section 12 of the Equal Opportunity Act 2010 (VIC), the Department of Biochemistry and Pharmacology strongly encourages applications from suitably qualified female candidates. We intend that at least one of the two appointees will be a female.

About the Role

We have two positions available as a Senior Lecturer or Associate Professor, who will develop and maintain a high-level research program in a field of pharmacology that is complementary to existing areas of research strength in the Department. You will be encouraged to contribute to interdisciplinary research within the School of Biomedical Science and Faculty of Medicine, Dentistry and Health Sciences and the wider academic community. You will also join a successful team in delivering and supporting teaching and learning in pharmacology and therapeutics within the Department and the broader School of Biomedical Sciences.

In a typical week at work, you may:

About You

You are a confident communicatorwith a demonstratable proactive reflective teaching practice. Your highly-developed interpersonal skills allow you to work collaboratively with internal and external colleagues, and you are passionate about mentoring and guiding junior research staff in their academic trajectory.

Ideally, you will further have:

Benefits of Working with Us

In addition to having the opportunity to grow and be challenged, and to be part of a vibrant campus life, our people enjoy a range of rewarding benefits:

To find out more, please visithttps://about.unimelb.edu.au/careers/staff-benefits.

Be Yourself

At UoM, we value the unique backgrounds, experiences and contributions that each person brings to our community, and we encourage and celebrate diversity. Indigenous Australians, those identifying as LGBTQIA+, females, people of all ages, with disabilities or culturally diverse backgrounds are encouraged to apply for our roles. Our aim is to create a workforce that reflects the community in which we live.

Join Us!

If you feel this role is right for you, please submit your application including a brief cover letter, your resume and your responses against the selection criteria^ (found in the Position Description) for the role.

^For information to help you with compiling short statements to answer the selection criteria and competencies, please go tohttp://about.unimelb.edu.au/careers/selection-criteria

Should you require any reasonable adjustments with the recruitment process, please contact the Talent Acquisition team athr-talent@unimelb.edu.au.

Due to the impacts of COVID-19, we are currently prioritising applications with current valid working rights in Australia and candidates who are not affected by travel restrictions. Please see the latest updates to Australia's immigration and border arrangements: https://covid19.homeaffairs.gov.au/

The University of Melbourne is required to comply with applicable health guidance and directions issued from the Victoria Health Minister. The University of Melbourne requires all University of Melbourne employees to be fully vaccinated against COVID-19, unless an exemption order applies. All applicants therefore must meet this requirement when submitting an application.

Position description:Senior Lecturer, Associate Professor PD.docx

Applications close:30 JUNE 2022 11:55 PMAUS Eastern Standard Time

Follow this link:
Senior Lecturer or Associate Professor in Biochemistry and Pharmacology job with UNIVERSITY OF MELBOURNE | 295930 - Times Higher Education

Four Faculty Members, Five Alums Elected to National Academy of Sciences – Caltech

Four members of the Caltech faculty have been elected to the National Academy of Sciences (NAS) this year. Election to the academy is considered one of the highest professional honors that can be bestowed upon a scientist.

The faculty members elected to the NAS this year are Bil Clemons, the Arthur and Marian Hanisch Memorial Professor of Biochemistry; Linda Hsieh-Wilson, the Milton and Rosalind Chang Professor of Chemistry; Michael Elowitz, professor of biology and bioengineering and Howard Hughes Medical Institute Investigator; and Nicholas Scoville, the Francis L. Moseley Professor of Astronomy, Emeritus.

Bil Clemons uses the tools of biochemistry to explore the molecular building blocks of life. The structural biologists in the Clemons lab work on problems related to how membrane proteins are made and inserted into cell membranes and the chemistry of enzymes that catalyze the transfer of sugars onto lipids. The work aims toward basic biological understanding that may lead to the development of novel therapeutics. He joined the Caltech faculty in 2005.

Linda Hsieh-Wilson studies the molecular bases of fundamental processes in the brain using organic synthesis, biochemistry, molecular and cellular biology, and neurobiology. Her research aims to better understand how proteins and carbohydrate molecules are involved in the development of neurons and communication between neurons, and how these processes contribute to neuroplasticity and neurological disorders. She joined the Caltech faculty in 2000.

Michael Elowitz works in the fields of synthetic and systems biology. His research aims to enable the programming of new biological functions with molecular circuits of interacting genes and proteins. His lab's main strategy is to design and engineer synthetic circuits that allow cells to process, remember, and communicate information, often in unexpected ways. By designing synthetic circuits, his group is discovering fundamental principles of natural biological circuit design and providing foundations for new kinds of biomedical therapies. He joined the Caltech faculty in 2003.

Nicholas Scoville founded the Cosmic Evolution Survey (COSMOS), which probes the formation and evolution of galaxies as well as black holes, in 2003. He led the survey for its first 10 years. He also served as the director of the Owens Valley Radio Observatory (OVRO) from 1986 to 1996. More recently, he used Atacama Large Millimeter/submillimeter Array (ALMA) in Chile to study the evolution of more than 700 galaxies within the COSMOS survey field. He joined the Caltech faculty in 1984.

Additionally, five Caltech alumni were elected to the academy. They are France Crdova (PhD '79), former president of the National Science Foundation, current president of Science Philanthropy Alliance, member of the Caltech Board of Trustees, and 2007 recipient of Caltech's Distinguished Alumni Award; Lance Dixon (BS '82), professor at the SLAC National Accelerator Laboratory; Leonidas Guibas (BS '71, MS '71), Paul Pigott Professor of Computer Science and Electrical Engineering in the School of Engineering at Stanford University; William Jones (PhD '79), the Charles F. Houghton Professor of Chemistry at the University of Rochester; and Kate Scholberg (MS '91, PhD '97), the Arts & Sciences Distinguished Professor of Physics and Bass Fellow at Duke University.

See the article here:
Four Faculty Members, Five Alums Elected to National Academy of Sciences - Caltech

Research Fellow, Cancer Biology and Biochemistry job with UNIVERSITY OF MELBOURNE | 296107 – Times Higher Education

Location: ParkvilleRole type: Full time/Fixed-termfor 12 monthsFaculty: School of Biomedical SciencesDepartment/School: Department of Biochemistry and PharmacologySalary: Level A $77,171 - $104,717 (pro rata for part-time) p.a. plus 17% super

Founded in 1853, the University of Melbourne is Australias #1 university and is consistently ranked amongst the leading universities in the world. We are proud of our people, our commitment to research and teaching excellence, and our global engagement.

About theDepartment of Biochemistry and Pharmacology

The Department of Biochemistry and Pharmacology has critical mass, interdisciplinary teaching and a remarkable breadth and depth in research expertise that underpin our key themes of molecular understanding of biology and disease, translational research, drug discovery and development.

It is envisaged to consolidate the research activities of the new Department. With respect to teaching, the departments offerings are complementary, and we are looking forward to developing new courses across our joint areas of expertise.

About the Role

A highly motivated early career researcher is sought to join the Department of Biochemistry & Pharmacology, Faculty of Medicine, Dentistry & Health Sciences in the University of Melbourne. The successful applicant will drive the in vivo projects taking place in the lab, thus extensive experience with small animal handling and animal models of disease (preferably cancer) is essential.

In a typical week at work, you may:

About You

You are a confident communicator with an ability to be proactive and to use initiative to solve problems quickly and efficiently. Your highly developed organisational skills and record keeping capabilitieswill enable you toprioritise a range of tasks, manage time effectively and meet deadlines in a busy environment.

Ideally, you will further have:

Benefits of Working with Us

In addition to having the opportunity to grow and be challenged, and to be part of a vibrant campus life, our people enjoy a range of rewarding benefits:

To find out more, please visithttps://about.unimelb.edu.au/careers/staff-benefits.

Be Yourself

At UoM, we value the unique backgrounds, experiences and contributions that each person brings to our community, and we encourage and celebrate diversity. Indigenous Australians, those identifying as LGBTQIA+, females, people of all ages, with disabilities or culturally diverse backgrounds are encouraged to apply for our roles. Our aim is to create a workforce that reflects the community in which we live.

Join Us!

If you feel this role is right for you, please submit your application including a brief cover letter, your resume and your responses against the selection criteria^ (found in the Position Description) for the role.

^For information to help you with compiling short statements to answer the selection criteria and competencies, please go tohttp://about.unimelb.edu.au/careers/selection-criteria

Should you require any reasonable adjustments with the recruitment process, please contact the Talent Acquisition team athr-talent@unimelb.edu.au.

Due to the impacts of COVID-19, we are currently prioritising applications with current valid working rights in Australia and candidates who are not affected by travel restrictions. Please see the latest updates to Australia's immigration and border arrangements: https://covid19.homeaffairs.gov.au/

The University of Melbourne is required to comply with applicable health guidance and directions issued from the Victoria Health Minister. The University of Melbourne requires all University of Melbourne employees to be fully vaccinated against COVID-19, unless an exemption order applies. All applicants therefore must meet this requirement when submitting an application.

Position description:Research Fellow (Cancer Biology and Biochemistry) PD.doc

Applications close:1 JULY 2022 11:55 PMAUS Eastern Standard Time

View original post here:
Research Fellow, Cancer Biology and Biochemistry job with UNIVERSITY OF MELBOURNE | 296107 - Times Higher Education

Assistant Professor, Department of Biochemistry job with NATIONAL UNIVERSITY OF SINGAPORE | 296136 – Times Higher Education

Job Description

The National University of Singapore invites applications for an Assistant Professor for the Department of Biochemistry, Yong Loo Lin School of Medicine with an affiliation to the Healthy Longevity Translational Research Programme.

The successful candidate will be expected to:

Job Requirements

At NUS, the health and safety of our staff and students are one of our utmost priorities, and COVID-vaccination supports our commitment to ensure the safety of our community and to make NUS as safe and welcoming as possible. Many of our roles require a significant amount of physical interactions with students/staff/public members. Even for job roles that may be performed remotely, there will be instances where on-campus presence is required. Taking into consideration the health and well-being of our staff and students and to better protect everyone in the campus, applicants are strongly encouraged to have themselves fully COVID-19 vaccinated to secure successful employment with NUS.

See original here:
Assistant Professor, Department of Biochemistry job with NATIONAL UNIVERSITY OF SINGAPORE | 296136 - Times Higher Education

5 For The Fight announces new cancer research fellows – Utah Business – Utah Business

Provo5 For The Fight, a nonprofit started by Qualtrics and fueled by thousands of private donors, announced today that seven new cancer researchers will get a boost for their work thanks to $1.1 million in grants.

The five women and two men, who are part of the multi-year 5 For The Fight Cancer Research Fellows program, were vetted and chosen in part for their pledge to focus on research designed to:

What these cancer researchers have in common is grit and innovation, says Mike Maughan, 5 For The Fight co-founder. Their important work along with the work of other fellows in the program brings us one step closer to our goal to eradicate cancer. We are excited to fuel their progress and help give them a real chance to advance the field and help mentor those that come after them.

This is the third class of 5 For The Fight Cancer Research Fellows, which now totals over 30 researchers. Each researcher receives funding for three years and provides updates on findings annually. 5 For The Fight also has 15 cancer centers through other grants. Past 5 For The Fight Fellows have reported progress on research in colon cancer screenings for Black and Indigenous men, the study of how and why melanomas form, and the role of B cells in solid tumors, among other achievements. To date, 5 For The Fight has raised nearly $30 million to help eradicate cancer with 100 percent of those funds donated directly to the worlds leading cancer researchers.

All seven of the new fellowship recipients are located at Huntsman Cancer Institute at the University of Utah. For information on how to donate to support future fellows as well as other cancer researchers, please visitwww.5forthefight.org

About 5 For The Fight

5 For The Fight, a nonprofit started byQualtricsin 2017, is a global campaign inviting everyone to donate $5 to the fight against cancer. Each donation is made in honor of someone who is battling or has been touched by the disease. 5 For The Fight is featured on the Utah Jazz jersey patch and is the only cause-related jersey patch in the NBA. To join the fight, please visitwww.5forthefight.org.

2022-2025

5 For The Fight Cancer Research Fellows

Robert L. Dood, MD, MSCEis fighting to improve survival rates in people with gynecologic cancers. A surgeon-scientist specializing in gynecologic cancer and an assistant professor of obstetrics and gynecology at the University of Utah, Dood will pursue research to better understand specific tumor traits, and use these findings to advance insights into more effective treatment approaches. Dood completed his medical degree and a master of epidemiology at the University of Pennsylvania, followed by fellowship training in gynecologic oncology at the University of Texas M.D. Anderson Cancer Center.

Shreya Goel, PhDis fighting to improve imaging in pediatric cancer patients. Imaging is a tool used by doctors to assess whether a patient is responding to treatment. A pediatric cancer researcher and an assistant professor of pharmaceutics and pharmaceutical chemistry, Goel will advance study of new methods of imaging for pediatric cancers. She completed her PhD in materials science at the University of Wisconsin, followed by postdoctoral training in nanomedicine and cancer systems imaging at the University of Texas M.D. Anderson Cancer Center.

Crystal Lumpkins, PhD, MAis fighting to prevent cancers and improve outcomes in African American and Black immigrant populations through genetic testing and more effective communication. A cancer population scientist and associate professor of communication, Lumpkins will test new tools to improve communication about reducing cancer risk in minority populations. Lumpkins received her doctorate from the University of Missouri-Columbia and holds masters degrees in media communications and management from Webster University in St. Louis, Missouri.

Matt Miller, PhDis fighting to understand the underlying cellular changes that can lead to cancer and other diseases. A cancer biochemist and assistant professor and assistant professor of biochemistry, Miller is working to answer fundamental questions about how microscopic changes in chromosomes can lead to defects that precipitate the development of diseases like cancer and to use these insights to inform more effective strategies for prevention and treatment. Miller received his PhD in cell biology from the Massachusetts Institute of Technology, followed by postdoctoral training in biochemistry and biophysics at the Fred Hutchinson Cancer Research Center.

Ami Patel, MDis fighting to develop better treatments that will improve outcomes for people with blood cancers. As a physician-scientist and an assistant professor of internal medicine, Patel cares for patients with leukemia and will use the fellowship award to advance development of new clinical trials to assess treatments that will target leukemia cells. She completed medical training and an internal medicine residency at Northwestern University, followed by fellowship training in hematology-oncology at the Salt Lake Veterans Affairs Medical Center and the University of Utah.

Melissa Reeves, PhDis fighting to understand how certain tumor characteristics resist treatments. Reeves oversees a cancer research laboratory and is an assistant of pathology at the University of Utah. Reeves studies a tumor trait called heterogeneity. Heterogeneous tumors respond poorly to immunotherapy, and are common across many tumor types, including melanoma, lung cancer, bladder cancer, and kidney cancer. Yet they are resistant to all available treatments. Reeves plans to understand the barriers the immune system encounters fighting heterogeneous tumors and develop treatment strategies that will improve outcomes for patients. She completed her PhD in biomedical sciences from University of California San Francisco.

Arabella Young, PhDis a cancer immunologist and assistant professor of pathology who is fighting to understand how to safely deliver immunotherapy treatments for certain types of cancer. Almost all cancers can benefit from immunotherapy treatment meaning treatments that harness a patients own immune system to fight their tumor. Yet some internal systems in the patients immune system can create resistance to treatments. Young aims to engineer strategies that safely amplify the immune response to cancer. She completed a PhD in immunology from the University of Queensland, and postdoctoral training in tumor immunology and autoimmunity from University of California San Francisco.

View post:
5 For The Fight announces new cancer research fellows - Utah Business - Utah Business

Oladiji and the Fresh Fervour for FUTA – THISDAY Newspapers

Tunde Akanni

The news of the emergence of our very own Temidayo Adenike Oladiji, FAS, renowned professor of biochemistry, as the first female, new vice-chancellor of the Federal University of Technology, Akure stirred up an uncommon, ecstatic excitement in many of us. As a friend and colleague we now reckon with as a family member, we were more than proud.

But almost immediately, I remembered Ile-Ife. I remembered the ancient community in relation to a similar announcement for the great citadel of learning, OAU Ife, beclouded by strange decibels of confusion. Some folks who claimed to be Ife people wanted an indigene, by all means, to be VC. It didnt matter to them if their preferred candidate who did not make it this time could emerge next time around. They staged marches in their community going as far as the university campus to flaunt their fetish fangs, but the deed had been done and could not be undone. The university councils decision was final!

Beyond resounding condemnations that the unpopular protesters in Ile-Ife attracted to themselves, the historical reality of FUTA countered the ethnic jingoists. The sitting VC then, Prof Joseph Fuwape, hailed from Ile-Ife, but no one ever bothered about that. FUTA had been on the path of greatness and all everyone wanted was for the leadership to sustain this and possibly boost it.

Unfortunately, the Ife violence merchants seemed to have infected some pseudo-scholars, ironically in FUTA. In the same spirit with the minority Ife locals or so it seemed, Professor Oladiji stood condemned as the winner of the just concluded appointment process. Most distastefully, they found sheer illiterate collaborators in some media with passive or absent-minded editing. Otherwise how do you describe such media lapping up same headline with same story far from aligning with the headline? More disturbing really was the fact that even a particular title that had some of its journalists punished for a similar recklessness in the past got caught up with this! You will wonder for eternity why a news organization supposedly run by trained professionals will deliberately position itself in the path of progress of an ambitious university like FUTA.

Who is not in awe of the excellent job of public image management by our good friend and colleague, Adegbenro Adebanjo? What about the indomitability of FUTAs academics, by all means, active researchers combined with the alumni who have been relentless in upscaling the profile of their university globally? Expectedly, the informed voice of ASUU FUTA called out to controvert the earlier rancorous intervention smacking of unmistakable ignorance by folks not familiar with university tradition. How capacity deficient? How else could the council have told the story of how Temidayo Oladiji triumphed over her rivals in the contest for the VCs seat? How much more can we say FUTA needs Oladiji now more than any other time?

From accomplishing groundbreaking researches and winning internationally competitive grants across assorted disciplines of Agricultural Science to trendy engineering feats, FUTA has been recurrent. As a mentor and father to some engineering budding stars including a doctoral student in environmental engineering in England with a Commonwealth Scholarship up his sleeves, I have more than a passing interest in engineering and allied researches in which FUTA has come to distinguish itself. Time, again, has come for the ambitious university to move higher up on the scale of global ranking. And I make this valid claim based on my evaluation of the profile of the energetic, young VC just clocking 54.

Lets do this again together: Born Adenike Temidayo Folayan, the Biochemistry scholar belongs in the category of first generation of what has come to be known as Better by Far University. It was the same generation that produced the incumbent, high performing Vice-Chancellor of the Federal University of Lokoja, Kogi State, Prof Olayemi Akinwumi.

Young Adenike bagged a Second Class Upper Honours degree in Biochemistry in 1988. Notwithstanding the hard-hitting economic policy of the Structural Adjustment Programme, SAP, Kwara Breweries in Offa could not resist the brilliance exhibited by the young graduate in the course of examining their potential recruits. She was hired immediately. More than 25 years after leaving the brewery for the academia, Prof Oladiji keeps researching about food, gloriously sustaining the good memory of her humble beginning at Offa. Check out the list of research products developed from herbs by the new FUTA boss: AHRI Sweet Basilspices(listing with NAFDAC); Pangas Anti-anaemic supplement (being processed for regulatory approval); Blosorg Supplement (awaiting regulatory approval); Iron-fortified tomato and pepper paste(awaiting regulatory approval)

Since joining her alma mater, the University of Ilorin, as a lecturer, diligent Oladiji, in addition to being faithful to her primary responsibilities of teaching and researching, has served in several other capacities most meritoriously earning her multiple distinctions and research grants. How else could anyone have been sufficiently prepared for VCship?

A Guest Professor at the University of Gambia since 2012, she was at different times a Plenary Lecturer, Uka Tarsadia University in India and a Fellow of the Israeli Agency for International Development Cooperation in addition to being 1989 Federal Government of Nigeria Scholar as well as being a winner of the 1995-97 winner of the University of Ilorin Staff Development Award. It was therefore no wonder she emerged the lead researcher for the over N17 million NNPC Renewable Energy Research Project in 2019. That was even after leading multiple research projects supported by TETFUND.

Though a scientist, Oladiji is as much a public intellectual in a society notorious for partriarchy. In 2019 alone within a very short space of time, she delivered two highly celebrated public lectures. She was the guest speaker at that years valedictory ceremony of the popular Adeola College Offa. Soon afterwards, she did another major address at the Hooding Ceremony of the College of Pure and Applied Sciences of Landmark University, Omun Aran, Kwara State, to mention only two.

Perhaps most interesting about Oladiji is her clean triumph over typical Nigerian pettiness bothering on religion and ethnicity. Farouk, a professor of telecommunications based in Dutse once confessed to me how motherly, Oladiji was, to her wife when she was supervising her for a postgraduate programme. She was a mother to our daughter as well as the mother of the baby, my darling wife.

A most cosmopolitan Prof Oladiji also effortlessly deploys basic Islamic greetings to the admiration of many Muslims on account of her sociability and her vast educational exposure across all the continents. My personal interaction with her frankly betrays a personality without airs in spite of being so heavily credentialed at her age.

Its FUTAs turn to benefit from the thoroughness, speed and vigour of the Midas touch of the world class scholar they never had its like before having been brought in from outside FUTA and especially from a university that has remained the envy of others for several years netting awards from local and international quarters. For instance, Unilorin, Oladijis cradle and base till date, remains about the most internationalized university in Nigeria.

I can only enjoin FUTA to harvest the best from one of the best of nations best in the university system.

Akanni, PhD, a British Chevening Scholar, Associate Professor and Acting Head of Journalism Dept, LASU, doubles as the Director of Digital Media Research Centre, LASU.

Like Loading...

More:
Oladiji and the Fresh Fervour for FUTA - THISDAY Newspapers

Blue Devil of the Week: Friend to Students, Enemy of Disease – Duke Today

Name:Amanda Hargrove

Position:Associate Professor of Chemistry

Years at Duke:8

What she does at Duke:In her role as a researcher, Amanda Hargrove, a2020 Alfred P. Sloan Research Fellowand anAmerican Chemical Society 2022 Rising Star Award winner, heads a lab that studies a specific type of RNA molecule and its potential role in breakthrough therapies.

In every cell, ribonucleic acid, or RNA, plays a critical role in carrying genetic information and directing the formation of proteins. But not all of the RNA molecules do this. The RNA molecules that arent involved in these processes what scientists call non-coding RNA were once thought to be fairly inconsequential. But in recent years, researchers have discovered that these molecules are involved in the process that allows cancer and viruses to spread.

Hargroves lab is studying ways to disrupt the function of this type of RNA and, potentially, find therapies that can better fight cancer and protect against viruses, such as the agent behind Hand, Foot and Mouth Disease and COVID-19.

The idea is that, maybe the reason we dont have as many cancer drugs as wed like is that weve been going after the wrong class of molecules, Hargrove said.

Aside from research, Hargrove is the chair of her departments Diversity, Inclusion and Community Committee and serves aseditor-in-chiefof the journalMedicinal Research Reviews. She also teaches courses, including undergraduate and graduate level courses on organic chemistry and chemical biology as well as a seminar for first-year students meant to give them an early glimpse of authentic scientific research by letting them develop and test their own hypotheses.

You can almost see their gears working, Hargrove said of her students. Its so much fun to watch.

What she loves about Duke:Hargrove appreciates that Dukes brilliant minds arent bound by their academic disciplines. She said collaboration has been a constant part of her Duke experience as faculty are curious and supportive of one anothers work. She remembers feeling this in her earliest days at Duke when colleagues introduced her to a variety of other faculty members who they predicted shed work with at some point.

Hargrove said this collaborative energy has resulted in projects which have seen her team up withcolleagues from the Duke Cancer Institute, the Department of Biochemistry and elsewhere.

I could tell from the beginning that, at Duke, community mattered, Hargrove said.

When shes not working, she likes to:Hargrove loves spending time with her 13-year old son and 8-year old daughter. From watching them practice taekwondo or indulging their recent obsession of baking shows, she finds great joy in spending time with her kids.

One of the great things about having kids and a family is that it gives you an identity thats not related to your job, Hargrove said. If something happens in your job, youve got this whole other role thats more important. It makes dealing with the ups and downs of your job easier to manage.

Best advice received:Hargrove recallsfellow scientist Laura Mahaltelling her that networking is more than building contacts. Its creating a trusted group invested in your success. Mahal said one effective way to build this group is by asking for help and acting on guidance.

Once people give you advice, and they see you take it, theyre invested in your success because they contributed to it, Hargrove said. Thats a good way to build a network that sticks with you and supports you.

Something most people dont know about her:When Hargrove attended Trinity University in San Antonio, Texas, she did so with help from a rodeo scholarship. While the Houston-native grew up around rural environments, she never took part in any rodeo-related activities. Instead her scholarship was an academic honor awarded by theHouston Livestock Show and Rodeo, which, in addition to being a Texas agriculture tradition, is also a major supporter of the states top students.

I like telling people about that, but it would have made for a cooler story if Id gotten it for raising cattle or riding horses, Hargrove said.

Most memorable day at work:In November of 2019, Hargrove was working at her desk in the French Family Science Center when she got a text fromBlanton Tolbert, a chemistry professor at Case Western Reserve University. The two had been working on a project to see if a small molecule could bind to the RNA in the EV71 virus to inhibit transmission and eventually kill the virus. Tolbert had just gotten his hands on data that showed thatthe idea worked.

He didnt wait for an email, he just texted me a picture of the result and said Did you see this? Hargrove said. It was so exciting. I actually printed out that chart and carried it around in my backpack for a year.

Something unique in her workspace:On Hargroves desk, theres a large metal H-shaped basket that is slowly filling up with champagne corks. Each cork has a name and a date on it. The corks are from the bottles opened to celebrate each paper and successful Ph.D. defense for students Hargrove works with.

Mentoring students and post-docs is one of my favorite parts of the job, Hargrove said. When something great happens for them, its just the very, very best.

Lesson learned during the pandemic:Hargrove gained a new appreciation for how important it is for a university to put the needs of its people at the forefront. While the research and educational missions are essential, the pandemic underscored the value of making sure the students, faculty and staff at the heart of those missions are healthy and safe.

It was really impressive to me how much people could come together, the Duke community in particular, Hargrove said. I did feel really grateful to be in this community. I dont think there was a better place to be a faculty member during something like that.

Is there a colleague at Duke who has an intriguing job or goes above and beyond to make a difference?Nominate that personfor Blue Devil of the Week.

Read more:
Blue Devil of the Week: Friend to Students, Enemy of Disease - Duke Today